Free tool
Stocks near their 52-week high
We cover 36 companies trading within 5% of their own 52-week high. The median market value in the group is $13.13B. Across the group, the median move over the past trading day is +0.92%. 97% of the 35 with a 200-day average trade above it. Price change over the past year runs from +4.1% to +70.6% across the middle 80 percent of the group, with a median of +33.0%.
Other lists in this group
Table
36 of 3,992 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| LLY.DE | Eli Lilly and Company | $1.07T | Mega cap | +73.55% |
| JNJ.DE | Johnson & Johnson | $651.71B | Mega cap | +58.93% |
| 4AB.DE | AbbVie Inc. | $471.29B | Mega cap | +32.34% |
| RHO.DE | Roche Holding AG | $370.84B | Mega cap | +41.42% |
| TN8.DE | Thermo Fisher Scientific Inc. | $234.00B | Mega cap | +29.67% |
| GIS.DE | Gilead Sciences, Inc. | $184.35B | Large cap | +33.64% |
| PFE.DE | Pfizer Inc. | $161.11B | Large cap | +22.96% |
| VX1.DE | Vertex Pharmaceuticals Incorporated | $139.82B | Large cap | +41.64% |
| DC4.DE | DexCom, Inc. | $33.35B | Large cap | +21.06% |
| IDP.DE | Biogen Inc. | $32.39B | Large cap | +65.32% |
| SOBI.ST | Swedish Orphan Biovitrum AB (publ) | $16.99B | Large cap | +61.26% |
| IPN.PA | Ipsen S.A. | $15.97B | Large cap | +40.80% |
| ESF0.DE | Eurofins Scientific SE | $14.67B | Large cap | +12.65% |
| ORNBV.HE | Orion Oyj | $13.16B | Large cap | +21.01% |
| ORNAV.HE | Orion Oyj | $13.11B | Large cap | +21.27% |
| REC.MI | Recordati Industria Chimica e Farmaceutica S.p.A. | $12.57B | Large cap | +1.80% |
| DEMANT.CO | Demant A/S | $9.36B | Mid cap | +17.12% |
| GETI-B.ST | Getinge AB (publ) | $7.01B | Mid cap | +20.89% |
| 1SXP.DE | SCHOTT Pharma AG & Co. KGaA | $4.08B | Mid cap | +1.26% |
| BBZA.DE | BB Biotech AG | $3.87B | Mid cap | +7.22% |
| DRW3.DE | Drägerwerk AG & Co. KGaA | $2.45B | Mid cap | +70.53% |
| VIMIAN.ST | Vimian Group AB (publ) | $1.99B | Small cap | +12.01% |
| ATT.ST | Attendo AB (publ) | $1.77B | Small cap | +80.74% |
| AMS.L | Advanced Medical Solutions Group plc | $830.96M | Small cap | +38.01% |
| UU8.F | Neurogene Inc. | $795.50M | Small cap | +165.60% |
| HNSA.ST | Hansa Biopharma AB (publ) | $450.66M | Small cap | +35.65% |
| LIK.DE | LIMES Schlosskliniken AG | $199.75M | Small cap | +70.66% |
| INIFY.OL | INIFY Laboratories AB | $81.09M | Micro cap | +44.55% |
| GXI.SW | Gerresheimer AG | — | — | +2.10% |
| LONN.SW | Lonza Group AG | — | — | +4.28% |
| NOVN.SW | Novartis AG | — | — | +30.24% |
| RO.SW | Roche Holding AG | — | — | +41.81% |
| ROP.SW | Roche Holding AG | — | — | +47.60% |
| SDZ.SW | Sandoz Group AG | — | — | +47.80% |
| TECN.SW | Tecan Group AG | — | — | +19.14% |
| YPSN.SW | Ypsomed Holding AG | — | — | +4.01% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.